Is pharma's rep among doctors on the upswing?

Drugmakers may be heartened to hear that doctors' perceptions of the pharmaceutical industry have actually improved this year, the first time since 2004 that their positive feelings grew. Consumers, however, grew slightly more negative about pharma. Report

Suggested Articles

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

Patients receiving Bavencio actually did worse than those who got placebo, increasing the risk of death by 31%.

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.